defends her dissertation in Radiochemistry entitled ” MSc Salla Lahdenpohja Synthesis of ” on 19.3.2021 at 12.00 in Laurén 2 Lecture Hall (Medisiina D, Kiinamyllynkatu 10, 20520 Turku). Due to the current COVID situation, the audience can participate in the defence by remote access – link will be provided here closer to the event. 18F-labelled radiopharmaceuticals for CNS imaging: From radiosynthesis development to GMP production
Opponent: Prof. Raisa Krasikova (Russian Academy of Science), Custos: Adj. prof.
Anna Kirjavainen (University of Turku).
Adj.prof. Xiang-Guo Li was awarded a group leader position in the InFLAMES Flagship program! Congratulations!
The Academy of Finland has granted
research infrastructure funding for setting up new radiopharmaceutical chemistry laboratory in the new chemistry building, Aurum. Yippee!
We’ve again received positive funding decisions as Adj. Prof. Xiang-Guo Li got funding from the
Cancer Foundation Finland for his research “Homing peptide-based radiopharmaceuticals for imaging brain tumors using positron emission tomography”.
In addition, our doctoral candidate
MSc Lahdenpohja got a grant from the Orion Research Foundation sr to finalize her doctoral thesis.
Academy of Finland was generous with our group this year as both
prof. Solin and Dr. Kirjavainen got funding for the next four years!
A lot of fascinating science with carbon-11 and fluorine-18 coming up in the forthcoming years, stay tuned!